國立臺灣大學 |
2005 |
Arsenic Suppresses Gene Expression in Promyelocytic Leukemia Cells Partly through Sp1 Oxidation
|
周文堅; 俞松良; 楊泮池; CHOU, WEN-CHIEN; YU, SUNG-LIANG; YANG, PAN-CHYR |
臺大學術典藏 |
2020-06-17T03:02:01Z |
Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation
|
Chou W.-C.;Chen H.-Y.;Sung-Liang Yu;Cheng L.;Yang P.-C.;Dang C.V.; Chou W.-C.; Chen H.-Y.; SUNG-LIANG YU; Cheng L.; Yang P.-C.; Dang C.V. |
臺大學術典藏 |
2021-02-05T06:29:49Z |
Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation
|
Wen-Chien Chou;Chen H.-Y.;Yu S.-L.;Cheng L.;Yang P.-C.;Dang C.V.; WEN-CHIEN CHOU; Chen H.-Y.; Yu S.-L.; Cheng L.; Yang P.-C.; Dang C.V. |
國立東華大學 |
2006-03-26 |
Arsenic Toxicity and Environmental Problem-Blackfoot Disease in Taiwan
|
瞿港華; Chiu, Kong-Hwa;Wang, Joanna Shaofen |
臺北醫學大學 |
2002 |
Arsenic toxicity on duck spermatozoa and the ameliorating of L-ascorbic acid
|
邱弘毅; Lin CC; Huang CC; Chen MC; Huang Andrew JF; Chiou HY |
亞洲大學 |
2012-05 |
Arsenic trioxide (As(2) O(3) ) inhibits murine WEHI-3 leukemia in BALB/c mice in vivo.
|
鍾景光;Chung, Jing-Gung |
國立臺灣大學 |
2010 |
Arsenic Trioxide Alleviates Airway Hyperresponsiveness and Eosinophilia in a Murine Model of Asthma
|
朱冠驊; 李珍珍; 江伯倫; CHU, KUAN-HUA; LEE, CHEN-CHEN; CHIANG, BOR-LUEN |
中國醫藥大學 |
2010-06 |
Arsenic trioxide alleviates airway hyperresponsiveness and eosinophilia in a murine model of asthma
|
(Kuan-Hua Chu); 李珍珍(Chen-Chen Lee); (Shao-Chi Hsin); (Bao-Chang Cai); (Jin-Hong Wang); (Bor-Luen Chiang)* |
臺大學術典藏 |
2021-07-02T03:41:56Z |
Arsenic trioxide alleviates airway hyperresponsiveness and eosinophilia in a murine model of asthma
|
Chu K.-H.; Lee C.-C.; Hsin S.-C.; Cai B.-C.; Wang J.-H.; BOR-LUEN CHIANG |
國立成功大學 |
2011-09-05 |
Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways
|
Ho, Sheng-Yow; Wu, Wei-Jr; Chiu, Hui-Wen; Chen, Yi-An; Ho, Yuan-Soon; Guo, How-Ran; Wang, Ying-Jan |
國立臺灣大學 |
2002 |
Arsenic Trioxide as a Novel Anticancer Agent against Human Transitional Carcinoma - Characterizing Its Apoptotic Pathway
|
蒲永孝; 侯自銓; 陳淳; 黃昭淵; 官靜儀; PU, YEONG-SHIAU; HOUR, TZYH-CHYUAN; CHEN, JUN; HUANG, CHAO-YUAN; GUAN, JING-YI |
臺大學術典藏 |
2021-10-14T02:46:20Z |
Arsenic trioxide as a novel anticancer agent against human transitional carcinoma - Characterizing its apoptotic pathway
|
Pu Y.-S.; Hour T.-C.; Chen J.; CHAO-YUAN HUANG; Guan J.-Y.; Lu S.-H. |
臺大學術典藏 |
2021-02-02T00:47:05Z |
Arsenic trioxide as a novel anticancer agent against human transitional carcinoma - Characterizing its apoptotic pathway
|
Yeong-Shiau Pu;Hour T.-C.;Chen J.;Huang C.-Y.;Guan J.-Y.;Lu S.-H.; YEONG-SHIAU PU; Hour T.-C.; Chen J.; Huang C.-Y.; Guan J.-Y.; Lu S.-H. |
臺北醫學大學 |
2003 |
Arsenic trioxide can partially but not completely eradicate leukemic cells in the NOD/SCID animal model of human acute myeloid leukemia
|
劉興璟; Lin YY; Lin SF; Huang MJ; Lin CP; Lu JD; Chow JM; Liu HJ |
國立成功大學 |
2012-02-20 |
Arsenic Trioxide Enhances the Radiation Sensitivity of Androgen-Dependent and -Independent Human Prostate Cancer Cells
|
Chiu, Hui-Wen; Chen, Yi-An; Ho, Sheng-Yow; Wang, Ying-Jan |
國立臺灣大學 |
2008 |
Arsenic trioxide impairs spermatogenesis via reducing gene expression levels in testosterone synthesis pathway
|
Chiou, Tzeon-Jye; Chu, Sin-Tak; Tzeng, Woan-Fang; Huang, Yu-Chen; Liao, Chi-Jr |
臺大學術典藏 |
2007 |
Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial
|
Hsu W.-L.; Cheng A.-L.; Yang C.-H.; Lin C.-C.; CHIUN HSU; Hsu C.-H. |
國立臺灣大學 |
2007 |
Arsenic Trioxide in Patients with Hepatocellular Carcinoma: A Phase Ii Trial
|
林家齊; 許駿; 徐志宏; 許瑋玲; 鄭安理; 楊志新; LIN, CHIA-CHI; HSU, CHIUN; HSU, CHIH-HUNG; HSU, WEI-LING; CHENG, ANN-LII; YANG, CHIH-HSIN |
臺大學術典藏 |
2020-04-10T12:51:25Z |
Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial
|
Yang C.-H.; Cheng A.-L.; Lin C.-C.;Chiun Hsu;Hsu C.-H.;Hsu W.-L.;Cheng A.-L.;Yang C.-H.; Lin C.-C.; Chiun Hsu; Hsu C.-H.; Hsu W.-L. |
臺大學術典藏 |
2007 |
Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial
|
Yang C.-H.;Cheng A.-L;Hsu W.-L;Hsu C.-H;Hsu C;Chia-Chi Lin; Chia-Chi Lin; Hsu C; Hsu C.-H; Hsu W.-L; Cheng A.-L; Yang C.-H. |
臺大學術典藏 |
2020-05-26T09:27:25Z |
Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial
|
Lin C.-C; Hsu C; Hsu C.-H; Hsu W.-L; Cheng A.-L; CHIH-HSIN YANG |
臺大學術典藏 |
2021-09-01T02:02:07Z |
Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial
|
Lin C.-C.; Hsu C.; Hsu C.-H.; Hsu W.-L.; ANN-LII CHENG; Yang C.-H. |
臺大學術典藏 |
2022-09-15T01:09:54Z |
Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial
|
Chia-Chi Lin; Hsu C.; Hsu C.-H.; Hsu W.-L.; Cheng A.-L.; Yang C.-H. |
國立成功大學 |
2011-09 |
Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin
|
Chiu, Hui-Wen; Ho, Yuan-Soon; Wang, Ying-Jan |
國立成功大學 |
2015-01-28 |
Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells
|
Chiu, Hui-Wen; Tseng, Yin-Chiu; Hsu, Yung-Ho; Lin, Yuh-Feng; Foo, Ning-Ping; Guo, How-Ran; Wang, Ying-Jan |